| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Interim CEO And CSO | Chief Scientific Officer
1 company
Brenner Martin is a See Remarks at IBIO. Recent filings cover 1 purchase and 15 sales. Those positions are worth an estimated $26K at current prices.
Our model assigns Brenner Martin a strong insider score of 87/100, based on 12 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +72.5%.
Brenner Martin's largest disclosed position is in IBIO as See Remarks, worth about $26K. The recent filings there lean toward selling, a net 83,655 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23, 2023 | IBIO Ibio, Inc. | See Remarks | Sell | 5,213 | $2.13 | $11,111.51 | -2.4% | -67.2% | -97.3% | |
| Feb 21, 2023 | IBIO Ibio, Inc. | See Remarks | Sell | 3,976 | $1.77 | $7,037.52 | -1.8% | -44.1% | -96.4% |